BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25143060)

  • 21. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
    Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
    Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography.
    Maruyama H; Takahashi M; Ishibashi H; Okugawa H; Okabe S; Yoshikawa M; Yokosuka O
    Liver Int; 2009 May; 29(5):708-14. PubMed ID: 18803588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of sonazoid for hepatic metastasis: comparison with FDG PET/CT.
    Hiraoka A; Kume M; Miyagawa M; Tazuya N; Ichiryu M; Ochi H; Tanabe A; Nakahara H; Shinbata Y; Kan M; Doi S; Hidaka S; Uehara T; Tanihira T; Hasebe A; Miyamoto Y; Ninomiya T; Hirooka M; Abe M; Hiasa Y; Matsuura B; Onji M; Michitaka K
    Hepatogastroenterology; 2010; 57(102-103):1237-40. PubMed ID: 21410065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of contrast-enhanced ultrasonograpy with Gd-EOB-DTPA-enhanced MRI in the diagnosis of liver metastasis from colorectal cancer.
    Shiozawa K; Watanabe M; Ikehara T; Matsukiyo Y; Kogame M; Kikuchi Y; Otsuka Y; Kaneko H; Igarashi Y; Sumino Y
    J Clin Ultrasound; 2017 Mar; 45(3):138-144. PubMed ID: 27861987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of sentinel lymph nodes by contrast-enhanced ultrasonography with Sonazoid in patients with breast cancer: a feasibility study in three hospitals.
    Shimazu K; Ito T; Uji K; Miyake T; Aono T; Motomura K; Naoi Y; Shimomura A; Shimoda M; Kagara N; Kim SJ; Noguchi S
    Cancer Med; 2017 Aug; 6(8):1915-1922. PubMed ID: 28766883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response evaluation of transcatheter arterial chemoembolization in hepatocellular carcinomas: the usefulness of sonazoid-enhanced harmonic sonography.
    Xia Y; Kudo M; Minami Y; Hatanaka K; Ueshima K; Chung H; Hagiwara S; Inoue T; Ishikawa E; Kitai S; Takahashi S; Tatsumi C; Ueda T; Hayaishi S; Maekawa K
    Oncology; 2008; 75 Suppl 1():99-105. PubMed ID: 19092278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined use of contrast-enhanced intraoperative ultrasonography and a fluorescence navigation system for identifying hepatic metastases.
    Uchiyama K; Ueno M; Ozawa S; Kiriyama S; Shigekawa Y; Yamaue H
    World J Surg; 2010 Dec; 34(12):2953-9. PubMed ID: 20734045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of sonazoid-ultrasonography during hepatectomy in patients with liver tumors: A preliminary study.
    Nanashima A; Tobinaga S; Abo T; Kunizaki M; Takeshita H; Hidaka S; Taura N; Ichikawa T; Sawai T; Nakao K; Nagayasu T
    J Surg Oncol; 2011 Feb; 103(2):152-7. PubMed ID: 21259249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kupffer-phase findings of hepatic hemangiomas in contrast-enhanced ultrasound with sonazoid.
    Sugimoto K; Moriyasu F; Saito K; Yoshiara H; Imai Y
    Ultrasound Med Biol; 2014 Jun; 40(6):1089-95. PubMed ID: 24556559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of local tumor residue after percutaneous radiofrequency ablation therapy for hepatocellular carcinoma.
    Hamanaka J; Goto T; Nishigori S; Seki S; Ida T; Morohashi T; Ohara H; Inamori M; Maeda S
    Turk J Gastroenterol; 2017 May; 28(3):197-201. PubMed ID: 28294951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma.
    Kudo M; Hatanaka K; Maekawa K
    Oncology; 2010 Jul; 78 Suppl 1():40-5. PubMed ID: 20616583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histology-Based Assessment of Sonazoid-Enhanced Ultrasonography for the Diagnosis of Liver Metastasis.
    Kobayashi K; Maruyama H; Kiyono S; Yokosuka O; Ohtsuka M; Miyazaki M; Matsushima J; Kishimoto T; Nakatani Y
    Ultrasound Med Biol; 2017 Oct; 43(10):2151-2158. PubMed ID: 28755791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of contrast-enhanced ultrasound using perfluorobutanecontaining microbubbles as a planning for percutaneous biopsies of focal hepatic lesions: a prospective feasibility study.
    Lee SM; Kim JH; Yang HK; Kang HJ; Han JK
    Med Ultrason; 2019 May; 21(2):109-116. PubMed ID: 31063512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.
    Hatanaka K; Kudo M; Minami Y; Ueda T; Tatsumi C; Kitai S; Takahashi S; Inoue T; Hagiwara S; Chung H; Ueshima K; Maekawa K
    Intervirology; 2008; 51 Suppl 1():61-9. PubMed ID: 18544950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of colorectal hepatic metastases: Contrast-enhanced ultrasonography versus contrast-enhanced computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging with diffusion-weighted imaging.
    Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Kitamura T; Faima Z; Fukushima K; Araki T; Iino H; Mori Y; Fujii H
    J Magn Reson Imaging; 2010 Nov; 32(5):1132-40. PubMed ID: 21031519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US.
    Min JH; Lim HK; Lim S; Kang TW; Song KD; Choi SY; Rhim H; Lee MW
    Clin Mol Hepatol; 2014 Mar; 20(1):61-70. PubMed ID: 24757660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The detection of pCR after PST by contrast-enhanced ultrasonography for breast cancer.
    Fujisawa T; Hirakata T; Yanagita Y; Iijima M; Horikoshi H; Takeuchi K; Saitoh Y
    Breast Cancer; 2013 Jan; 20(1):75-82. PubMed ID: 22203579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common occurrence of benign liver lesions in patients with newly diagnosed breast cancer investigated by MRI for suspected liver metastases.
    Noone TC; Semelka RC; Balci NC; Graham ML
    J Magn Reson Imaging; 1999 Aug; 10(2):165-9. PubMed ID: 10441020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three cases of histologically proven hepatic epithelioid hemangioendothelioma evaluated using a second-generation microbubble contrast medium in ultrasonography: case reports.
    Arai J; Shimozuma Y; Otoyama Y; Sugiura I; Nakajima Y; Hayashi E; Kajiwara A; Omori R; Uozumi S; Miyashita M; Uchikoshi M; Doi H; Sakaki M; Wang T; Eguchi J; Ito T; Kurihara T; Munechika J; Gokan T; Saito K; Miura S; Tate G; Takimoto M; Yoshida H
    BMC Gastroenterol; 2019 Nov; 19(1):187. PubMed ID: 31727083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic tumor imaging using iron oxide MRI: comparison with computed tomography, clinical impact, and cost analysis.
    Schultz JF; Bell JD; Goldstein RM; Kuhn JA; McCarty TM
    Ann Surg Oncol; 1999; 6(7):691-8. PubMed ID: 10560856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.